Kinetics of early fIV infection in cats exposed via the vaginal versus intravenous route

AIDS Research and Human Retroviruses

Volumn 18, Issue 3, 2002, Pages 217-226

  Burkhard, Mary Jo ^a   Mathiason, Candace K ^a   O'Halloran, Kevin ^a   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; CORRELATION FUNCTION; FELINE IMMUNODEFICIENCY VIRUS; INOCULATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VAGINITIS; VIREMIA; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; CATS; CELL DIVISION; DNA, VIRAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; INCIDENCE; INJECTIONS, INTRAVENOUS; KINETICS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; RNA, VIRAL; SPLEEN; T-LYMPHOCYTE SUBSETS; VAGINA; VIREMIA;

EID: 0036179770     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220252781284     Document Type: Article

References (58)

1. Gender differences in HIV-1 diversity at time of infection
2. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties
3. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
4. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission
5. Comparison of variable region 3 sequences of human immunode-ficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers
6. Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: Differences in semen and blood HIV-1 RNA and proviral DNA
7. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood
8. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1
9. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques
10. Replication capacity of simian immunodeficiency virus in cultured macaque macrophages and dendritic cells is not prerequisite for intravaginal transmission of the virus in macaques
11. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
12. Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV
13. Mucosal transmission of virulent and avirulent lentiviruses in macaques
14. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques
15. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV
16. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks
17. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression
18. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus
19. Feline immunodeficiency virus clade C mucosal transmission and disease courses
20. Vaginal and rectal infection of cats with feline immunodeficiency virus
21. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: Nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum
22. Mucosally transmitted feline immunodeficiency virus induces a CD81 antiviral response that correlates with reduction of cell-associated virus
23. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns
24. In vivo monocyte tropism of pathogenic feline immunodeficiency viruses
25. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse tran-scriptase PCR
26. Vertical transmission of feline immunodeficiency virus
27. Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats
28. Maternal-fetal feline immunodeficiency virus transmission: Timing and tissue tropisms
29. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus
30. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone
31. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo
32. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR
33. Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: Implications for glutamate uptake
34. Neurotoxic effects of feline immunodeficiency virus, FIV-PPR
35. Feline immunodeficiency virus: A Neurotropic lentivirus
36. Flow cytometric analysis of T-lymphocyte subsets in cats
37. Characterization of a panel of monoclonal antibodies specific for subsets of feline leukocytes
38. Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus
39. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage
40. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia
41. Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS
42. SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque
43. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus
44. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism
45. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus
46. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells
47. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
48. Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men
49. Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia
50. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
51. Progesterone implants enhance SIV vaginal transmission and early virus load
52. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251
53. Long-term effects of antiretroviral combination therapy on HIV type 1 DNA levels
54. Plasma virus load evaluation in relation to disease progression in HIV-infected children
55. Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV cohort study
56. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses
57. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages
58. Lymphocyte activation during acute simian/human immunodeficiency virus SHIV (89.6PD) infection in macaques